Table 7.
Stability of bupropion and metabolites in human urine.
| Stability in urine (%)a (n = 3) | 
||||
|---|---|---|---|---|
| Analyte | Nominal Concentration (ng/mL) | 1stfreeze-thaw | 2ndfreeze-thaw | 3rdfreeze-thaw | 
| (R)-bupropion | 25 | 101 ± 8 | 98 ± 5 | 88 ± 4 | 
| 1000 | 103 ± 2 | 98 ± 11 | 91 ± 3 | |
| (S)-bupropion | 25 | 112 ± 6 | 99 ± 5 | 93 ± 11 | 
| 1000 | 108 ± 7 | 95 ± 12 | 90 ± 6 | |
| (R,R)-hydroxybupropion | 100 | 96 ± 7 | 86 ± 10 | 88 ± 5 | 
| 15,000 | 105 ± 5 | 99 ± 5 | 97 ± 6 | |
| (S,S)-hydroxybupropion | 100 | 92 ± 2 | 88 ± 9 | 88 ± 5 | 
| 15,000 | 105 ± 6 | 100 ± 7 | 97 ± 6 | |
| (1S,2S)-threohydrobupropion | 250 | 97 ± 8 | 96 ± 2 | 88 ± 6 | 
| 2500 | 104 ± 4 | 98 ± 7 | 95 ± 6 | |
| (1R,2R)-threohydrobupropion | 250 | 93 ± 7 | 99 ± 3 | 88 ± 6 | 
| 2500 | 103 ± 6 | 97 ± 7 | 94 ± 7 | |
| (1R,2S)-erythrohydrobupropion | 250 | 96 ± 11 | 96 ± 4 | 87 ± 7 | 
| 2500 | 105 ± 6 | 98 ± 6 | 95 ± 7 | |
| (1S,2R)-erythrohydrobupropion | 250 | 97 ± 9 | 99 ± 5 | 89 ± 5 | 
| 2500 | 104 ± 4 | 97 ± 6 | 94 ± 6 | |
| (1S,2S)-threohydrobupropion β-d-glucuronide | 100 | 99 ± 10 | 97 ± 2 | 91 ± 4 | 
| 2500 | 105 ± 5 | 100 ± 9 | 97 ± 7 | |
| (1 R,2R)-threohydrobupropion β-d-glucuronide | 100 | 100 ± 11 | 103 ± 1 | 97 ± 9 | 
| 2500 | 105 ± 7 | 102 ± 8 | 97 ± 7 | |
| (1R,2S)-erythrohydrobupropion β-d-glucuronide | 100 | 102 ± 5 | 104 ± 3 | 97 ± 5 | 
| 2500 | 105 ± 6 | 100 ± 7 | 98 ± 7 | |
Reported values are the percentage of the initial observed concentration (prepared freshly with no freeze thaw cycles), mean ± standard deviation, n = 3.